CRVS
#2356
Corvus Pharmaceuticals, Inc. - Common Stock
14.1 7 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.74%
Variación mensual
+6.06%
Variación en los últimos 6 meses
-19.03%
Cambio anual
+161.44%
Cierres anteriores
14.7 2
Open
14.3 1
Mínimo
14.1 7
Máximo
14.3 5
Volumen
77
Financials
- Market Capitalization 1.19 B
- Employee 37
- Founded 2014
- CEO N/A
- Website www.corvuspharma.com
- Headquarter Delaware, United States
- FIGI BBG009F0TGH8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14.53
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2334 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.97 USD | -2.93% | +0.76% | +21.04% | +31.02% | 1.19 B USD | ||
| 2351 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.77 USD | -3.84% | -6.83% | -38.06% | +21.86% | 1.17 B USD | ||
| 2372 |  KURA Kura Oncology, Inc. - Common Stock | 12.76 USD | -3.19% | +6.51% | +37.50% | +56.95% | 1.14 B USD | ||
| 2383 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.45 USD | -1.76% | +4.71% | +23.66% | -20.13% | 1.13 B USD |